Abstract 2949: Palazestrant, a CERAN, in combination with OP-3136, a KAT6 inhibitor, synergistically downregulates cell proliferation and metastasis related gene signatures.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Susanna A. Barratt, Gopinath S. Palanisamy, Azita Ghodssi, Chelsea Hope, Guadelupe Peña, Srinivasan Jayaraman, Raymond A. Ng, David C. Myles
Institution: Olema Pharmaceuticals (United States)
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148842332
Cites:
Cited by:
Related to: